V. Orlandi, G. Bersani - Vol. 7, Settembre 2001, num.3
Testo Immagini Bibliografia Summary Riassunto Indice
Assunzione di cannabis e schizofrenia: rapporto
con esordio, decorso e psicopatologia
Cannabis and schizophrenia: relationships with onset, clinical course
and psychopathology
1 Robins LN, Regier DA. Psychiatric Disorders in America. New York: free press 1991.
2 Kessler RC, McGonagh KA, Zaho S, Nelson CB, Hughes M, Eshleman, et al. Lifetime and 12-month prevalence of DSM II-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
3 European Monitoring Centre for Drugs and Drug Addiction. Annual report on the state of drugs problem in the European Union. EMCDDA 1995.
4 Mueser KT, Yarnold PR, Levinson DR, Singh H, Bellack AS, Kee K, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31-56.
5 Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psichiatr Scand 1992;85:48-55.
6 Mueser KT, Yarnold PR, Rosemberg SD, Sweet C, Miles KM, Hill D. Substance use disorder in hospitalised severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophr Bull 2000;26:179-92.
7 Kovasznay B, Fleischer J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997;23:195-201.
8 Kovasznay B, Bromet E, Schwarz JE, Ram R, Lavelle J, Brandon L. Substance abuse and onset of psychotic illness. Hosp Community Psychiatry 1993;44:567-71.
9 Hollister LE. Health aspects of cannabis. Pharmacol Rev 1986;38:1-20.
10 Hollister LE. Cannabis-1988. Acta Psichiatr Scand 1988;345(Suppl.):108-11.
11 Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-9.
12 Caspari D. Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 1999;249:45-9.
13 Arndt S, Tyrrel G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 1992;22:379-88.
14 Kosten TR, Ziedonis DM. Substance abuse and schizophrenia: editor’s introduction. Schizophr Bull 1997;23:181-6.
15 McDonald C, Murray RM. Early and late environmental risk factors for schizophrenia. Brain Res Rev 2000;31:130-7.
16 Hambrecht M, Hafner H. Cannabis, vulnerability and the onset of schizophrenia: an epidemiological perspective. Aust NZJ Psychiatry 2000;34:468-75.
17 Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;ii:1483-6.
18 Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 1989;79:505-10.
19 Jones P, Cannon M. The new epidemiology of schizophrenia. Psychiatr Clin North Am 1998;21:1-25.
20 Barry KL, Fleming MF, Greenley JR, Kropp S, Widlak P. Characteristics of persons with severe mental illness and substance abuse in rural areas. Psychiatr Serv 1996;47:88-90.
21 Owen RR, Fischer EP, Booth BM, Cuffel B. J. Medication non-compliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996;47:853-8.
22 Negrete JC, Knapp WP, Douglas D, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986;16:515-20.
23 Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not in neurocognitive function. J Clin Psychiatry 1991;52:26-30.
24 Negrete JC. Psychiatric effects of cannabis use. In: Fehr K, Kalant H, eds. Cannabis and Health Hazards. Toronto: Addiction Research Foundation 1983:577-616.
25 Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992;85:127-30.
26 Dixon L, Haas G, Weiden PJ, Sweeney, Frances AJ. Drug abuse in schizophrenia: clinical correlates and reasons for use. Am J Psychiatry 1991;148:224-30.
27 Thornicroft G. Cannabis and psychosis: is the epidemiological evidence for an association? Br J Psychiatry 1990;157:25-33.
28 Allebeck P, Adamsson C, Engstrom A, Rydberg U. cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand 1993;88:21-4.
29 Silver H, Abboud E. Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophr Res 1994;13:57-63.
30 De Quardo JR, Carpenter CF, Tandon R. Patterns of substance abuse in schizophrenia: natural and significance. J Psychiat Res 1994;28:267-75.
31 Hambrecth M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996;40:1155-63.
32 Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment Dis 1987;175:641-52.
33 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, IV. Washington DC: APA press 1994.
34 Andreasen NC. The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa 1984.
35 Andreasen NC. The scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa 1983.
36 Kay SR, Fiszbein A, Opler LA. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
37 Lehman AF, Myers CP, Corty CP. Assessment and classification of patients with psychiatric and substance syndromes. Hosp Community Psychiatry 1989;40:1019-25.
38 Soni SD, Gaskell K, Reed P. Factors affecting rehospitalisation rates of chronic schizophrenic patients living in the community. Schizophr Res 1994;12:169-77.
39 Gray R, Thomas B. Effects of cannabis abuse on people with serious mental health problems. Br J Nurs 1996;5:230-3.
40 Bowers MB, Jrmazure CM, Nelson JC, Jatlov PI. Psychotogenic drug use and neuroleptic response. Schizophr Bull 1990;16:81-5.
41 Dixon L,Weiden PJ, Haas G, Sweeney J, Frances AJ. Increased tardive diskinesia in alcohol abusing schizophrenic patients. Compr Psychiatry 1992;33:121-2.
42 Baigent M, Holme G, Hafner RJ. Self reports of the interaction between substance abuse and schizophrenia. Aus NZJ Psychiatry 1995;29:69-74.
43 Test MA, Wallisch LS, Allness DJ, Ripp K. Substance use in young adults with schizophrenic disorders. Schizophr Bull 1989;15:465-76.
44 Tsuang MP, Simpson JC, Kronfol Z. Subtypes of drug abuse with psychosis. Arch Gen Psychiatr 1982;39:141-7.
45 Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999;35:S93-S100.
46 Martin GW, Wilkinson A, Kapur BM. Validation of self-reported cannabis use by urine analysis. Addict Behav 1988;13:147-50.